Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types
byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple c
Updated on: January 29,2024
15

Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types
byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple c
Updated on:January 29,2024
15
